Targeting triple-negative breast cancers using nanomedicine
Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive, and metastatic
phenotype of breast cancer which accounts for about 15%–20% of all breast cancer cases …
phenotype of breast cancer which accounts for about 15%–20% of all breast cancer cases …